Parexel International Corp. (PRXL-Q) Stock Predictions - Stockchase
WATCH LIST
9
Parexel International Corp. (PRXL-Q)

ON STOCKCHASE SINCE Jul 2008

Acquired (Sept 2017)

biotechnology/pharmaceutical

Parexel International Cor...

PRXL-Q

1 watching          
Join the Discussion

Parexel International Corp. (PRXL-Q) SAVE Dec, 31, 1969, 7:00 pm

0.00 0 (100%)

This company is not ACTIVE.

What the experts are saying about PRXL-Q



  • All
  • Filtered
Signal Opinion Expert
PAST TOP PICK

(A Top Pick March 23/16. Up 9%.) Does clinical trials for the major drug producers, which is about 75% of their business. It’s been mildly disappointing. A very good company. They are growing their cash, which may lead to a dividend being paid in the near future. Very active in buying back shares. It has lots of potential.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments

(A Top Pick March 23/16. Up 9%.) Does clinical trials for the major drug producers, which is about 75% of their business. It’s been mildly disappointing. A very good company. They are growing their cash, which may lead to a dividend being paid in the near future. Very active in buying back shares. It has lots of potential.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Gordon Reid

President, GoodReid Investment ...

Price Price
$65.370
Owned Owned
Yes

TOP PICK

A contract research organization that basically takes outsourced clinical studies on behalf of pharmaceuticals, runs the studies through various phases on behalf of them. They have $5.4 billion of backlog. Have just gone through a restructuring process which will be additive in the last half of this year to their earnings.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments

A contract research organization that basically takes outsourced clinical studies on behalf of pharmaceuticals, runs the studies through various phases on behalf of them. They have $5.4 billion of backlog. Have just gone through a restructuring process which will be additive in the last half of this year to their earnings.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Gordon Reid

President, GoodReid Investment ...

Price Price
$59.400
Owned Owned
Yes

PAST TOP PICK
(A Top Pick April 27/11. Down 2.73%.) Contract research for Pharma companies. Very good company. Now going into partnership with large pharmas.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
(A Top Pick April 27/11. Down 2.73%.) Contract research for Pharma companies. Very good company. Now going into partnership with large pharmas.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Gordon Reid

President, GoodReid Investment ...

Price Price
$26.770
Owned Owned
Yes

PAST TOP PICK
(Top Pick Apr 27/11, Down 5.79%) Clinical trial company. It is an efficient model
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
(Top Pick Apr 27/11, Down 5.79%) Clinical trial company. It is an efficient model
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Gordon Reid

President, GoodReid Investment ...

Price Price
$26.160
Owned Owned
Yes

TOP PICK
Clinical trial management. They take phase 1 drugs and run them through the trials. About a $2.9 billion backlog and a book to bill of about $1.5 billion, meaning that for every $1 they bill, they get orders of $1.50.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Clinical trial management. They take phase 1 drugs and run them through the trials. About a $2.9 billion backlog and a book to bill of about $1.5 billion, meaning that for every $1 they bill, they get orders of $1.50.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Gordon Reid

President, GoodReid Investment ...

Price Price
$27.450
Owned Owned
Yes

PAST TOP PICK
(A Top Pick March 11/09. Up 180.8%.) About 60% of revenues come from outside the US.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
(A Top Pick March 11/09. Up 180.8%.) About 60% of revenues come from outside the US.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Gordon Reid

President, GoodReid Investment ...

Price Price
$21.840
Owned Owned
Yes

PAST TOP PICK
(Top Pick Mar 11/09, Up 163.6%) Not as cheap as it was, but still good value.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
(Top Pick Mar 11/09, Up 163.6%) Not as cheap as it was, but still good value.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Gordon Reid

President, GoodReid Investment ...

Price Price
$20.350
Owned Owned
Yes

TOP PICK
Contract research organization and do drug trials on behalf of pharmaceuticals and biopharmas. Stock has been beaten down on worries of lack of pipeline and foreign exchange worries.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Contract research organization and do drug trials on behalf of pharmaceuticals and biopharmas. Stock has been beaten down on worries of lack of pipeline and foreign exchange worries.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Gordon Reid

President, GoodReid Investment ...

Price Price
$7.760
Owned Owned
Yes

TOP PICK
Contract research that does clinical drug trials for major drug companies. Strong growing franchise.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Contract research that does clinical drug trials for major drug companies. Strong growing franchise.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Gordon Reid

President, GoodReid Investment ...

Price Price
$25.900
Owned Owned
Yes

Showing 1 to 9 of 9 entries
Successfully Saved Company
Successfully Saved Company